1. Home
  2. PHAT vs ASPN Comparison

PHAT vs ASPN Comparison

Compare PHAT & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • ASPN
  • Stock Information
  • Founded
  • PHAT 2018
  • ASPN 2001
  • Country
  • PHAT United States
  • ASPN United States
  • Employees
  • PHAT N/A
  • ASPN N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • ASPN RETAIL: Building Materials
  • Sector
  • PHAT Health Care
  • ASPN Consumer Discretionary
  • Exchange
  • PHAT Nasdaq
  • ASPN Nasdaq
  • Market Cap
  • PHAT 640.9M
  • ASPN 638.5M
  • IPO Year
  • PHAT 2019
  • ASPN 2014
  • Fundamental
  • Price
  • PHAT $8.35
  • ASPN $7.61
  • Analyst Decision
  • PHAT Strong Buy
  • ASPN Strong Buy
  • Analyst Count
  • PHAT 5
  • ASPN 10
  • Target Price
  • PHAT $16.40
  • ASPN $21.78
  • AVG Volume (30 Days)
  • PHAT 937.1K
  • ASPN 2.2M
  • Earning Date
  • PHAT 08-07-2025
  • ASPN 08-07-2025
  • Dividend Yield
  • PHAT N/A
  • ASPN N/A
  • EPS Growth
  • PHAT N/A
  • ASPN N/A
  • EPS
  • PHAT N/A
  • ASPN N/A
  • Revenue
  • PHAT $81,859,000.00
  • ASPN $436,921,000.00
  • Revenue This Year
  • PHAT $195.03
  • ASPN N/A
  • Revenue Next Year
  • PHAT $106.77
  • ASPN $24.31
  • P/E Ratio
  • PHAT N/A
  • ASPN N/A
  • Revenue Growth
  • PHAT 3055.70
  • ASPN 51.90
  • 52 Week Low
  • PHAT $2.21
  • ASPN $4.16
  • 52 Week High
  • PHAT $19.71
  • ASPN $33.15
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 47.45
  • ASPN 59.45
  • Support Level
  • PHAT $7.61
  • ASPN $7.36
  • Resistance Level
  • PHAT $9.23
  • ASPN $8.34
  • Average True Range (ATR)
  • PHAT 0.66
  • ASPN 0.48
  • MACD
  • PHAT -0.08
  • ASPN 0.01
  • Stochastic Oscillator
  • PHAT 30.64
  • ASPN 64.15

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

Share on Social Networks: